| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A family history of cancer and lung cancer risk in never-smokers: A clinic-based case–control study
|
Lin, Huan
|
|
2015
|
89 |
2 |
p. 94-98
5 p.
|
article
|
| 2 |
A randomized phase II study of bevacizumab in combination with docetaxel or S-1 in patients with non-squamous non-small-cell lung cancer previously treated with platinum based chemotherapy (HANSHIN Oncology Group 0110)
|
Nishino, Kazumi
|
|
2015
|
89 |
2 |
p. 146-153
8 p.
|
article
|
| 3 |
Contents
|
|
|
2015
|
89 |
2 |
p. v-vi
nvt p.
|
article
|
| 4 |
Corrigendum to “High resolution CT in differentiating minimally invasive component in early lung adenocarcinoma” [Lung Cancer 84 (2014) 236–241]
|
Zhang, Yu
|
|
2015
|
89 |
2 |
p. 222-
1 p.
|
article
|
| 5 |
Could less be more?—A systematic review and meta-analysis of sublobar resections versus lobectomy for non-small cell lung cancer according to patient selection
|
Cao, Christopher
|
|
2015
|
89 |
2 |
p. 121-132
12 p.
|
article
|
| 6 |
Editorial Board
|
|
|
2015
|
89 |
2 |
p. iii-
1 p.
|
article
|
| 7 |
FDG-PET maximum standardized uptake value is prognostic for recurrence and survival after stereotactic body radiotherapy for non-small cell lung cancer
|
Kohutek, Zachary A.
|
|
2015
|
89 |
2 |
p. 115-120
6 p.
|
article
|
| 8 |
Feasibility of home delivery of pemetrexed in patients with advanced non-squamous non-small cell lung cancer
|
Lal, R.
|
|
2015
|
89 |
2 |
p. 154-160
7 p.
|
article
|
| 9 |
Lung cancer at the intensive care unit: The era of targeted therapy
|
Adam, Valerie
|
|
2015
|
89 |
2 |
p. 218-221
4 p.
|
article
|
| 10 |
Methyl(R217)HuR and MCM6 are inversely correlated and are prognostic markers in non small cell lung carcinoma
|
Vigouroux, Charlène
|
|
2015
|
89 |
2 |
p. 189-196
8 p.
|
article
|
| 11 |
Non-small cell lung cancer recurrence following surgery and perioperative chemotherapy: Comparison of two chemotherapy regimens (IFCT-0702: A randomized phase 3 final results study)
|
Moro-Sibilot, Denis
|
|
2015
|
89 |
2 |
p. 139-145
7 p.
|
article
|
| 12 |
Patient-derived tumor xenograft models established from samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration
|
Nakajima, Takahiro
|
|
2015
|
89 |
2 |
p. 110-114
5 p.
|
article
|
| 13 |
PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma
|
Cooper, Wendy A.
|
|
2015
|
89 |
2 |
p. 181-188
8 p.
|
article
|
| 14 |
Racial disparities in the use of SBRT for treating early-stage lung cancer
|
Corso, Christopher D.
|
|
2015
|
89 |
2 |
p. 133-138
6 p.
|
article
|
| 15 |
Rehabilitation in patients with radically treated respiratory cancer: A randomised controlled trial comparing two training modalities
|
Salhi, Bihiyga
|
|
2015
|
89 |
2 |
p. 167-174
8 p.
|
article
|
| 16 |
Renal insufficiency is the leading cause of double maintenance (bevacizumab and pemetrexed) discontinuation for toxicity to advanced non-small cell lung cancer in real world setting
|
Sassier, Marion
|
|
2015
|
89 |
2 |
p. 161-166
6 p.
|
article
|
| 17 |
Research priorities in mesothelioma: A James Lind Alliance Priority Setting Partnership
|
Stephens, R.J.
|
|
2015
|
89 |
2 |
p. 175-180
6 p.
|
article
|
| 18 |
SABR for aggressive local therapy of metastatic cancer: A new paradigm for metastatic non-small cell lung cancer
|
Westover, Kenneth D.
|
|
2015
|
89 |
2 |
p. 87-93
7 p.
|
article
|
| 19 |
Screening for ALK in non-small cell lung carcinomas: 5A4 and D5F3 antibodies perform equally well, but combined use with FISH is recommended
|
Savic, Spasenija
|
|
2015
|
89 |
2 |
p. 104-109
6 p.
|
article
|
| 20 |
Silencing of miR-137 by aberrant promoter hypermethylation in surgically resected lung cancer
|
Kang, Nahyeon
|
|
2015
|
89 |
2 |
p. 99-103
5 p.
|
article
|
| 21 |
The impact of clinical characteristics on outcomes from maintenance therapy in non-small cell lung cancer: A systematic review with meta-analysis
|
Zhou, Fei
|
|
2015
|
89 |
2 |
p. 203-211
9 p.
|
article
|
| 22 |
The incidence and clinical impact of bone metastases in non-small cell lung cancer
|
Kuchuk, Michael
|
|
2015
|
89 |
2 |
p. 197-202
6 p.
|
article
|
| 23 |
Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and England
|
Damhuis, R.A.
|
|
2015
|
89 |
2 |
p. 212-217
6 p.
|
article
|
Journal description